NEW YORK (GenomeWeb) – Metabolomic Diagnostics said this week it raised €750,000 ($848,000) in a second funding round that brings the total amount of investments in the firm to €1.5 million. 

Based in County Cork, Ireland, Metabolomic Dx is developing a predictive diagnostic test for the early detection of pre-eclampsia during pregnancy. The firm named SOSVentures Ireland Fund and AIB Seed Capital Fund as investors. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.